Bogdana Victoria Kadunc, Adriana Amorim Vanti
Surg Cosmet Dermatol. 2009;1(1):10-14
Abstract
PDF Portuguese
Introduction: Phenol has been used in medicine for several decades, but many aspects of its systemic toxicity are not completely known.
Objective: Evaluating the renal and cardiac toxicities of phenol absorbed percutaneously in facial peelings.
Material and methods: A prospective, comparative, randomized study was undertaken with 4 groups of 15 patients each, with 4 different types of facial peelings: pure, at 50 and 88% in continuous applications, pure at 88%, and associated with Baker’s Formula with applications at specific time intervals. Urinary levels of this substance were determined by gas chromatography and cardiac changes by a continuous electrocardiogram for 24 hours (Holter).
Results: Gas chromatography showed fast phenol elimination in the urine, with a half-life of 6 to 8 hours. Cardiac changes seen on the Holter were observed in all groups, which stopped immediately without medical intervention.
Conclusions: Phenol, used in facial peelings, does not affect renal function, but it can cause arrhythmias in susceptible individuals, which are not related with the concentration or technique used.